Evolution of infectious bronchitis virus in the field after homologous vaccination introduction.
Animals
Biological Evolution
Chickens
Coronavirus Infections
/ prevention & control
Infectious bronchitis virus
/ immunology
Italy
Poultry Diseases
/ prevention & control
RNA, Viral
/ genetics
Spike Glycoprotein, Coronavirus
/ genetics
Vaccination
Vaccines, Attenuated
/ pharmacology
Viral Vaccines
/ pharmacology
Journal
Veterinary research
ISSN: 1297-9716
Titre abrégé: Vet Res
Pays: England
ID NLM: 9309551
Informations de publication
Date de publication:
09 Nov 2019
09 Nov 2019
Historique:
received:
17
06
2019
accepted:
25
09
2019
entrez:
11
11
2019
pubmed:
11
11
2019
medline:
3
3
2020
Statut:
epublish
Résumé
Despite the fact that vaccine resistance has been typically considered a rare phenomenon, some episodes of vaccine failure have been reported with increasing frequency in intensively-raised livestock. Infectious bronchitis virus (IBV) is a widespread avian coronavirus, whose control relies mainly on extensive vaccine administration. Unfortunately, the continuous emergence of new vaccine-immunity escaping variants prompts the development of new vaccines. In the present work, a molecular epidemiology study was performed to evaluate the potential role of homologous vaccination in driving IBV evolution. This was undertaken by assessing IBV viral RNA sequences from the ORF encoding the S1 portion of viral surface glycoprotein (S) before and after the introduction of a new live vaccine on broiler farms in northern-Italy. The results of several biostatistics analyses consistently demonstrate the presence of a higher pressure in the post-vaccination period. Natural selection was detected essentially on sites located on the protein surface, within or nearby domains involved in viral attachment or related functions. This evidence strongly supports the action of vaccine-induced immunity in conditioning viral evolution, potentially leading to the emergence of new vaccine-escape variants. The great plasticity of rapidly-evolving RNA-viruses in response to human intervention, which extends beyond the poultry industry, is demonstrated, claiming further attention due to their relevance for animal and especially human health.
Identifiants
pubmed: 31706335
doi: 10.1186/s13567-019-0713-4
pii: 10.1186/s13567-019-0713-4
pmc: PMC6842459
doi:
Substances chimiques
RNA, Viral
0
Spike Glycoprotein, Coronavirus
0
Vaccines, Attenuated
0
Viral Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
92Subventions
Organisme : Department of Animal Medicine, Production and Health, University of Padua
ID : BIRD187958/18
Références
Vet Microbiol. 2010 Nov 20;146(1-2):24-34
pubmed: 20447777
Avian Pathol. 2010 Apr;39(2):123-31
pubmed: 20390547
J R Soc Interface. 2007 Oct 22;4(16):803-17
pubmed: 17264055
Vaccine. 2016 Jan 12;34(3):380-6
pubmed: 26620841
Nat Rev Microbiol. 2004 Apr;2(4):279-88
pubmed: 15031727
Avian Pathol. 2017 Feb;46(1):28-35
pubmed: 27329854
Nucleic Acids Res. 2016 Jul 8;44(W1):W232-5
pubmed: 27084950
PLoS Biol. 2015 Jul 27;13(7):e1002198
pubmed: 26214839
Bioinformatics. 2005 Mar 1;21(5):676-9
pubmed: 15509596
Infect Genet Evol. 2016 Apr;39:349-364
pubmed: 26883378
Arch Virol. 2005 Sep;150(9):1813-31
pubmed: 15868095
Avian Pathol. 2008 Oct;37(5):487-93
pubmed: 18798022
PLoS Comput Biol. 2012;8(5):e1002507
pubmed: 22589711
Avian Pathol. 1999 Dec;28(6):593-605
pubmed: 27266431
Vaccine. 2005 Jul 14;23(32):4158-66
pubmed: 15964484
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Mol Ecol. 2016 Jan;25(1):42-66
pubmed: 26578204
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Mol Biol Evol. 2005 May;22(5):1208-22
pubmed: 15703242
Virus Res. 2014 Dec 19;194:37-48
pubmed: 25451062
Vaccine. 2014 Nov 28;32(50):6765-7
pubmed: 25446828
Vet Immunol Immunopathol. 2015 Nov 15;168(1-2):49-55
pubmed: 26315775
Avian Pathol. 1999 Oct;28(5):477-85
pubmed: 26911602
Sci Rep. 2016 Dec 19;6:39458
pubmed: 27991573
Nature. 2001 Dec 13;414(6865):751-6
pubmed: 11742400
Vaccine. 2016 Nov 4;34(46):5670-5676
pubmed: 27670071
PLoS Pathog. 2018 Apr 23;14(4):e1007009
pubmed: 29684066
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Mol Biol Evol. 2013 May;30(5):1196-205
pubmed: 23420840
Infect Genet Evol. 2012 Aug;12(6):1305-11
pubmed: 22609285
PLoS Genet. 2012;8(7):e1002764
pubmed: 22807683
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
J Gen Virol. 1992 Mar;73 ( Pt 3):591-6
pubmed: 1372036
PLoS One. 2017 Sep 7;12(9):e0184401
pubmed: 28880958
Vet Res. 2007 Mar-Apr;38(2):281-97
pubmed: 17296157
J Immunol Res. 2015;2015:424860
pubmed: 25954763
Avian Pathol. 2011 Jun;40(3):223-35
pubmed: 21711181
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W7-13
pubmed: 20435676
Arch Virol. 2018 Sep;163(9):2601-2631
pubmed: 29754305